Poly(ADP-ribose) and cancer research.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002273:Carcinogens / Q000633:toxicity; D002471:Cell Transformation, Neoplastic; D004260:DNA Repair; D006801:Humans; D009154:Mutation; D009244:NAD+ Nucleosidase / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics*; D009702:Nucleoside Diphosphate Sugars / Q000235:genetics*; D011064:Poly Adenosine Diphosphate Ribose / Q000235:genetics*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism*; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents; D002273:Carcinogens; D009702:Nucleoside Diphosphate Sugars; D011064:Poly Adenosine Diphosphate Ribose; D011065:Poly(ADP-ribose) Polymerases; D009244:NAD+ Nucleosidase